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Pharmacological and Biochemical Aspects Several substances, taken orally, actively interfere with one of the early stages of reproduction (Nelson 1961 ) but current commercial preparations are all mixtures of an cestrogen and a progestogen. Tablets of identical composition are taken, one daily, on the 5th -24th days of the artificial cycle. The cestrogen component is either ethinyl cestradiol or its 3-methyl ether, mestranol; the progestogen ingredient is usually a 19norsteroid derivative, only one drug house
The efficiency of oral contraceptives in controlling fertility is amply attested by the reports of numerous clinical trials (Mears & Grant 1962 , Pullen 1962 , Mears 1963 , but their mode of action remains in doubt (Holmes & Mandl 1962) . Follicular maturation appears to be inhibited at an early stage, precluding ovulation. The rates of excretion of oestrone, cestriol and pregnanediol are depressed but the total urinary gonadotrophins remain unchanged (Loraine et al. 1963) . This suggests that follicular suppression is effected by direct action on the ovary and is not mediated through the pituitary. However, the present method of bio-assay of human pituitary gonadotrophin does not discriminate between the follicle-stimulating and the luteinizing hormones favouring an ester of 1 7-hydroxyprogesterone (Table 1) . As judged by their ability to postpone menstruation and to control dysfunctional uterine himorrhage, 19-norsteroids are the most potent of the -oral progestogens. Their intrinsic (estrogenic activity or that of their metabolites may be an important adjunct in preventing conception. Androgenicity is neither an essential nor a desirable property (Table 2) . and would not demonstrate differential inhibition of either moiety. Within the range of the progestogen dosage in oral contraceptive tablets it appears that the cestrogen plays the dominant role in suppressing ovulation. Clinical trials conducted in Birmingham (Eckstein et al. 1961) and Slough (Pullen 1962) showed that the dose of oestrogen becomes critical as the progestogen component is reduced. The tablets contained norethynodrel 2 5 mg but the mestranol content was 0 05 mg and 0-I mg respectively. The failure rate was 29 % in Birmingham but only 1 % in Slough. Goldzieher et al. (1963) secured effective contraception by administering cestrogen alone on the 5th -19th days of the cycle followed by cestrogen and progestogen on the 20th-24th days. The dose of mestranol was only 0-08 mg daily, less than that contained in any commercial tablet except the original form of Conovid which includes a large, compensatory, dose of 19-norsteroid. The progestogen was the 17-hydroxyprogesterone derivative, chlormadinone, 2 mg daily. The failure rate in 938 women during 6,314 cycles was less than one per 100 woman-years which accords with the best results of simultaneous, as opposed to sequential, medication. The oestrogen component of oral contraceptives may mimic the effect of the successful graafian follicle which outstrips and suppresses other aspirants during the normal menstrual cycle.
The progestogen is relegated to the role of controlling the endometrium in respect of breakthrough and withdrawal bleeding and of avoiding endometrial hyperplasia. Records of uterine bleeding during clinical trials on two trade preparations containing ethinyl oestradiol in identical amount but different doses of norethisterone acetate lend support to this hypothesis (Mears 1963, personal communication) . For the patient's convenience intermenstrual bleeding should be eliminated; for her peace of mind withdrawal bleeding must occur and simulate normal menstruation. These requirements cannot be satisfied consistently by the present unphysiological practice of administering progestogens from the 5th day of the cycle. To avoid intermenstrual bleeding during early months the dose of 19-norsteroid must exceed the long-term optimum and this can lead to endometrial regression and amenorrhcea after several cycles. Sequential medication gives an endometrium histologically similar to the normal premenstrual mucosa and subsequent withdrawal bleeding repeatedly resembles a normal menstrual period.
Oral contraception of this type is more effective than physical or chemical methods and its future seems assured unless deleterious long-term sequelh are encountered. New steroid analogues with less immediate side-effects and modified dosage patterns can be anticipated. To avoid the 26and 27-day cycles inherent in the present 20-day regime treatment should be extended to 21 or 22 days. The provision of blank tablets for the remaining days in the cycle would lessen the risk of patient error. If the simultaneous treatment pattern persists, less progestogen could be advised after the first three months to avoid disquieting amenorrhcea and 1 7-hydroxyprogesterone derivatives. may well replace the 19norsteroids. However, the more physiological sequential regime should supersede the present simultaneous dosage scheme and incidentally give cestrogens die acknowledgment of their role in inhibiting ovulation.
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There is no question that a progestogen/oestrogen mixture, used in the familiar 5th-24th day regime for oral contraception, is the most efficient method of birth control we have ever had. A comparison of the efficiency of all methods of birth control, the failure rate being calculated as the number of pregnancies per 100 woman-years, and including patient as well as method failure, shows that the only other contraceptive method which approaches the Pincus pill in efficiency is the new plastic intrauterine device which is just beginning to be used in clinical trials in this country.
The method of administration of oral contraception allows for an occasional failure in tablet taking without consequent pregnancy. It is essential that the first tablet should be taken on day 5 of the first cycle, perhaps even earlier in the case of a woman with cycles of less than 24 days.
